Analgesic efficacy of enadoline versus placebo or morphine in postsurgical pain

Clinical Neuropharmacology

Volumn 19, Issue 5, 1996, Pages 451-456

  Pande, Atul C ^a   Pyke, Robert E ^a,c   Greiner, Martha ^a   Wideman, Gilder L ^b   Benjamin, Ronald ^a,d   Pierce, Mark W ^a  

^a PFIZER INC   (United States)

^b Brookwood Medical Center Birmingham   (United States)

^c Kendle Research Associates   (United States)

^d Astra/Merck Group   (United States)

Author keywords

Analgesia; Enadoline; Postsurgical pain; Opioid receptor

Indexed keywords

COCODAMOL; CODEINE; ENADOLINE; KAPPA OPIATE RECEPTOR; MORPHINE; NARCOTIC ANALGESIC AGENT; PARACETAMOL; PLACEBO;

ADULT; ANTINOCICEPTION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GYNECOLOGIC SURGERY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; NAUSEA; NEUROTOXICITY; OBSTETRIC ANALGESIA; OBSTETRIC ANESTHESIA; PAIN ASSESSMENT; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0029790082     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-199619050-00009     Document Type: Article

References (8)

1. Hunter JC, Leighton GE, Meecham KG, Boyle SJ, Horwell DC, Rees DC, Hughes J. CI-977, a novel and selective agonist for the κ-opioid receptor. Br J Pharmacol 1990;101:183-9.
2. Davis RE, Callahan MJ, Dickerson M, Downs DA. Pharmacologic activity of CI-977, a selective kappa opioid agonist, in rhesus monkeys. J Pharmacol Exp Ther 1992;261:1044-9.
3. Pande AC, Pyke RE, Greiner M, Cooper SA, Benjamin R, Pierce MW. Analgesic efficacy of the κ-receptor agonist, enadoline, in dental surgery pain. Clin Neuropharmacol 1996;19:92-7.
4. Rosland JH, Hole K. 1,4-Benzodiazepines antagonize opiate-induced antinociception in mice. Anesth Analg 1990;71:242-8.
5. Dawkins R, Lesback ME, Wright S, Posvar EL. Rising, single-dose tolerance, pharmacokinetics and pharmacodynamics of intramuscular CI-977. J Clin Pharmacol 1991;31:864.
6. Reece PA, Sedman AJ, Rose S, Wright DS, Dawkins R, Rajagopalan R. Diuretic effects, pharmacokinetis, and safety of a new centrally acting kappa opioid agonist (CI-977) in humans. J Clin Pharmacol 1994;34:1126-32.
7. Lambert PD, Barnes S, Woodruff GN, Hughes J, Hunter JC. Inhibition of L-glutamate release: a possible mechanism for the neuroprotective effects of the κ-selective agonist CI-977. Mol Neuropharmacol 1991;1:77-82.
8. Pinnock RD. A highly selective κ-opioid receptor agonist, CI-977, reduces excitatory postsynaptic potentials in the rat locus coeruleus in vitro. Neuroscience 1992;47:87-94.